Cancer stem cells and their potential implications for the treatment of solid tumors

Journal of Surgical Oncology

Volumn 106, Issue 2, 2012, Pages 209-215

  Grotenhuis, B A ^a   Wijnhoven, B P L ^a   Van Lanschot, J J B ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

cancer stem cell markers; cancer stem cells; cancer therapy; dissemination; targeted therapy; transplantation assay

Indexed keywords

CD133 ANTIGEN; CD34 ANTIGEN; CD38 ANTIGEN; CELL SURFACE MARKER; GRANULOCYTE COLONY STIMULATING FACTOR; MEMBRANE ANTIGEN; NOTCH RECEPTOR; REACTIVE OXYGEN METABOLITE; SALINOMYCIN; SONIC HEDGEHOG PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADJUVANT CHEMOTHERAPY; ANTIGEN EXPRESSION; BREAST CANCER; CANCER PATIENT; CANCER STEM CELL; CARCINOGENICITY; CELL DEATH; CELL DIFFERENTIATION; CELL DIVISION; CELL POPULATION; CELL RENEWAL; CELL SUBPOPULATION; CIRCULATING TUMOR CELL; COLON CANCER; CYTOTOXICITY; DNA DAMAGE; DNA MODIFICATION; EPITHELIAL MESENCHYMAL TRANSITION; FLUORESCENCE ACTIVATED CELL SORTING; HEMATOLOGIC MALIGNANCY; HUMAN; INTESTINE CANCER; LEUKEMIA CELL; METASTASIS; NONHUMAN; NONOBESE DIABETIC MOUSE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; SCID MOUSE; SOLID TUMOR; SPHEROID CELL; STEM CELL TRANSPLANTATION; STROMA CELL; TRANSPLANTATION; TUMOR ENGRAFTMENT; TUMOR GROWTH; TUMOR MICROENVIRONMENT; WNT SIGNALING PATHWAY;

ANIMALS; ANTIGENS, CD34; ANTIGENS, CD38; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; INTERLEUKIN-4; MICE; MOLECULAR TARGETED THERAPY; NEOPLASMS; NEOPLASTIC STEM CELLS; WNT SIGNALING PATHWAY;

EID: 84863715929     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23069     Document Type: Review

References (60)

1. Hanahan D, Weinberg RA:, The hallmarks of cancer. Cell 2000; 100: 57-70. (Pubitemid 30046295)
2. Reya T, Morrison SJ, Clarke MF, et al.: Stem cells, cancer, and cancer stem cells. Nature 2001; 414: 105-111. (Pubitemid 33041634)
3. Dick JE:, Stem cell concepts renew cancer research. Blood 2008; 112: 4793-4807.
4. Visvader JE, Lindeman GJ:, Cancer stem cells in solid tumours: Accumulating evidence and unresolved questions. Nat Rev Cancer 2008; 8: 755-768.
5. Bonnet D, Dick JE:, Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 1997; 3: 730-737. (Pubitemid 27298715)
6. Lapidot T, Sirard C, Vormoor J, et al.: A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 1994; 367: 645-648. (Pubitemid 24067706)
7. Quintana E, Shackleton M, Sabel MS, et al.: Efficient tumour formation by single human melanoma cells. Nature 2008; 456: 593-598.
8. Clarke MF, Dick JE, Dirks PB, et al.: Cancer stem cells-perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res 2006; 66: 9339-9344. (Pubitemid 44623625)
9. Morrison SJ, Kimble J:, Asymmetric and symmetric stem-cell divisions in development and cancer. Nature 2006; 441: 1068-1074. (Pubitemid 43990718)
10. Barker N, Ridgway RA, van Es JH, et al.: Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 2009; 457: 608-611.
11. Fodde R:, The stem of cancer. Cancer Cell 2009; 15: 87-89.
12. Mani SA, Guo W, Liao MJ, et al.: The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008; 133: 704-715. (Pubitemid 351636299)
13. Al-Hajj M, Wicha MS, Benito-Hernandez A, et al.: Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003; 100: 3983-3988. (Pubitemid 36418143)
14. McKenzie JL, Gan OI, Doedens M, et al.: Human short-term repopulating stem cells are efficiently detected following intrafemoral transplantation into NOD/SCID recipients depleted of CD122+ cells. Blood 2005; 106: 1259-1261. (Pubitemid 41129588)
15. Galli R, Binda E, Orfanelli U, et al.: Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res 2004; 64: 7011-7021. (Pubitemid 39331011)
16. Tseng W, Leong X, Engleman E:, Orthotopic mouse model of colorectal cancer. J Vis Exp 2007; 10: 484.
17. O'Brien CA, Pollett A, Gallinger S, et al.: A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007; 445: 106-110. (Pubitemid 46067310)
18. Ricci-Vitiani L, Lombardi DG, Pilozzi E, et al.: Identification and expansion of human colon-cancer-initiating cells. Nature 2007; 445: 111-115. (Pubitemid 46067311)
19. Kuperwasser C, Chavarria T, Wu M, et al.: Reconstruction of functionally normal and malignant human breast tissues in mice. Proc Natl Acad Sci USA 2004; 101: 4966-4971. (Pubitemid 38469186)
20. Kelly PN, Dakic A, Adams JM, et al.: Tumor growth need not be driven by rare cancer stem cells. Science 2007; 317: 337. (Pubitemid 47106366)
21. Kennedy JA, Barabe F, Poeppl AG, et al.: Comment on "Tumor growth need not be driven by rare cancer stem cells ". Science 2007; 318: 1722 author reply 1722.
22. Yuan X, Curtin J, Xiong Y, et al.: Isolation of cancer stem cells from adult glioblastoma multiforme. Oncogene 2004; 23: 9392-9400. (Pubitemid 40069671)
23. Dey D, Saxena M, Paranjape AN, et al.: Phenotypic and functional characterization of human mammary stem/progenitor cells in long term culture. PLoS One 2009; 4: e5329.
24. Thiery JP, Acloque H, Huang RY, et al.: Epithelial-mesenchymal transitions in development and disease. Cell 2009; 139: 871-890.
25. Thiery JP:, Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002; 2: 442-454.
26. Brabletz T, Jung A, Spaderna S, et al.: Opinion: Migrating cancer stem cells-an integrated concept of malignant tumour progression. Nat Rev Cancer 2005; 5: 744-749. (Pubitemid 41486367)
27. Fodde R, Brabletz T:, Wnt/beta-catenin signaling in cancer stemness and malignant behavior. Curr Opin Cell Biol 2007; 19: 150-158. (Pubitemid 46386404)
28. Iwatsuki M, Mimori K, Yokobori T, et al.: Epithelial-mesenchymal transition in cancer development and its clinical significance. Cancer Sci 101: 293-299.
29. Morel AP, Lievre M, Thomas C, et al.: Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS One 2008; 3: e2888.
30. Li L, Neaves WB:, Normal stem cells and cancer stem cells: The niche matters. Cancer Res 2006; 66: 4553-4557.
31. Moore KA, Lemischka IR:, Stem cells and their niches. Science 2006; 311: 1880-1885.
32. Vermeulen L, De Sousa EMF, van der Heijden M, et al.: Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nat Cell Biol 12: 468-476.
33. Gupta PB, Chaffer CL, Weinberg RA:, Cancer stem cells: Mirage or reality ? Nat Med 2009; 15: 1010-1012.
34. Gottesman MM, Fojo T, Bates SE:, Multidrug resistance in cancer: Role of ATP-dependent transporters. Nat Rev Cancer 2002; 2: 48-58. (Pubitemid 37328807)
35. Guan Y, Gerhard B, Hogge DE:, Detection, isolation, and stimulation of quiescent primitive leukemic progenitor cells from patients with acute myeloid leukemia (AML). Blood 2003; 101: 3142-3149. (Pubitemid 36858008)
36. Guzman ML, Neering SJ, Upchurch D, et al.: Nuclear factor-kappaB is constitutively activated in primitive human acute myelogenous leukemia cells. Blood 2001; 98: 2301-2307.
37. Kusumbe AP, Bapat SA:, Cancer stem cells and aneuploid populations within developing tumors are the major determinants of tumor dormancy. Cancer Res 2009; 69: 9245-9253.
38. Bao S, Wu Q, McLendon RE, et al.: Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006; 444: 756-760. (Pubitemid 44949604)
39. Liu G, Yuan X, Zeng Z, et al.: Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Mol Cancer 2006; 5: 67.
40. Creighton CJ, Li X, Landis M, et al.: Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features. Proc Natl Acad Sci USA 2009; 106: 13820-13825.
41. Li X, Lewis MT, Huang J, et al.: Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. J Natl Cancer Inst 2008; 100: 672-679.
42. Hermann PC, Huber SL, Herrler T, et al.: Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 2007; 1: 313-323. (Pubitemid 47355323)
43. Todaro M, Alea MP, Di Stefano AB, et al.: Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4. Cell Stem Cell 2007; 1: 389-402. (Pubitemid 47506537)
44. Todaro M, Lombardo Y, Francipane MG, et al.: Apoptosis resistance in epithelial tumors is mediated by tumor-cell-derived interleukin-4. Cell Death Differ 2008; 15: 762-772. (Pubitemid 351405081)
45. Diehn M, Cho RW, Lobo NA, et al.: Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature 2009; 458: 780-783.
46. Yeung TM, Mortensen NJ:, Colorectal cancer stem cells. Dis Colon Rectum 2009; 52: 1788-1796.
47. Wind J, Tuynman JB, Tibbe AG, et al.: Circulating tumour cells during laparoscopic and open surgery for primary colonic cancer in portal and peripheral blood. Eur J Surg Oncol 2009; 35: 942-950.
48. Schatton T, Frank NY, Frank MH:, Identification and targeting of cancer stem cells. Bioessays 2009; 31: 1038-1049.
49. Zhou BB, Zhang H, Damelin M, et al.: Tumour-initiating cells: Challenges and opportunities for anticancer drug discovery. Nat Rev Drug Discov 2009; 8: 806-823.
50. Jin L, Hope KJ, Zhai Q, et al.: Targeting of CD44 eradicates human acute myeloid leukemic stem cells. Nat Med 2006; 12: 1167-1174. (Pubitemid 44527352)
51. Schatton T, Murphy GF, Frank NY, et al.: Identification of cells initiating human melanomas. Nature 2008; 451: 345-349.
52. van Es JH, Clevers H:, Notch and Wnt inhibitors as potential new drugs for intestinal neoplastic disease. Trends Mol Med 2005; 11: 496-502. (Pubitemid 41653290)
53. Frank NY, Margaryan A, Huang Y, et al.: ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma. Cancer Res 2005; 65: 4320-4333. (Pubitemid 40775671)
54. Gupta PB, Onder TT, Jiang G, et al.: Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell 2009; 138: 645-659.
55. Saito Y, Uchida N, Tanaka S, et al.: Induction of cell cycle entry eliminates human leukemia stem cells in a mouse model of AML. Nat Biotechnol 28: 275-280.
56. Singh SK, Hawkins C, Clarke ID, et al.: Identification of human brain tumour initiating cells. Nature 2004; 432: 396-401. (Pubitemid 39551674)
57. Dalerba P, Dylla SJ, Park IK, et al.: Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci USA 2007; 104: 10158-10163. (Pubitemid 47175279)
58. Li C, Heidt DG, Dalerba P, et al.: Identification of pancreatic cancer stem cells. Cancer Res 2007; 67: 1030-1037.
59. Eramo A, Lotti F, Sette G, et al.: Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ 2008; 15: 504-514. (Pubitemid 351267301)
60. Yang ZF, Ho DW, Ng MN, et al.: Significance of CD90+ cancer stem cells in human liver cancer. Cancer Cell 2008; 13: 153-166. (Pubitemid 351163165)